Formic Acid Methyl Ester

Formic Acid Methyl Ester

SCHEMBL23716948

COC=O.Cc1ccc(F)cc1N

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
CASP1 P29466 1/20 0.42
CYP1A1 P04798 1/20 0.42
MAPT P10636 2/20 0.40
CYP3A4 P08684 2/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38
TUBA1C Q9BQE3 1/20 0.38
TUBB6 Q9BUF5 1/20 0.38
TUBB2B Q9BVA1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid Methyl Ester SCHEMBL28237553 0.85 ALDH1A1 (0.42) ALDH1A1TDP1CYP1A1CYP3A4TSHR
SCHEMBL29502013 0.84
SCHEMBL291685 0.84
Formic Acid Methyl Ester SCHEMBL28890219 0.81 CASP1 (0.68) ALDH1A1TDP1CASP1MAPTCYP3A4
Formic Acid Methyl Ester SCHEMBL27621281 0.79 ALDH1A1 (0.65) ALDH1A1TDP1MEN1KMT2AKEAP1
Formic Acid Methyl Ester SCHEMBL28165664 0.78 CYP3A4 (0.70) ALDH1A1TDP1CASP1MAPTCYP3A4
SCHEMBL8943124 0.76 CYP3A4 (0.48) ALDH1A1TDP1CASP1CYP1A1MAPT
Formic Acid Methyl Ester SCHEMBL27581497 0.75 NFE2L2 (0.44) ALDH1A1MAPTMEN1NPC1RAB9A
O-Tolylamine SCHEMBL28184600 0.72 TDP1 (0.62) ALDH1A1TDP1CASP1CYP3A4TSHR
Formic Acid Methyl Ester SCHEMBL28055986 0.71 ACHE (0.62) TDP1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459921-B2 Isoindoline compound, preparation method, pharmaceutical composition and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2025-11-04 US disclosed
US-20220041576-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2022-02-10 US disclosed
EP-3862348-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2021-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12459921-B2 Isoindoline compound, preparation method, pharmaceutical composition and use thereof CUL4B, CUL4A, UBQLN1 ALDH1A1 825/4885TDP1 3699/4885CASP1 3867/4885
US-20220041576-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF CUL4B, CUL4A, UBQLN1 ALDH1A1 825/4885TDP1 3699/4885CASP1 3867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.